Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01733004
Title A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merrimack Pharmaceuticals

Advanced Solid Tumor


Everolimus + MM-141


Gemcitabine + MM-141 + Nab-paclitaxel

Age Groups: adult
Covered Countries USA | FRA

No variant requirements are available.